Dr. Thai Huu Ho, MD, PhD

Dr. Ho practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Ho's NPI, 1326054115, was assigned on July 31, 2006. Dr. Ho graduated from Baylor College Of Medicine in 2006. Dr. Ho holds Arizona license 46460.

Dr. Ho's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Ho's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Ho is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Ho to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ho practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ho's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ho is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Ho's licenses on file in 5 states: Arizona, Missouri, South Carolina, Texas and California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Ho treats.

CMS data shows 261 Medicare services from Dr. Ho across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $18,099 for them.

CMS counts 74 Medicare patients who saw Dr. Ho in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ho's median patient age at 69, with 34% women.

In 2024, Dr. Ho wrote 375 Medicare Part D claims for 58 patients. 61% of them were for generic drugs. CMS names the drug for 289 of them, across 13 drugs with 11 or more claims each, at $1,136,115 in total drug cost. In 2023, CMS named 147 claims across 7 drugs.

Dr. Ho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ho as offering telehealth.

Dmand AI links 79 papers to Dr. Ho, published from 2002 to 2023. 2016 was the busiest year, with 9. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Gene Expression Regulation, Neoplastic. Dr. Ho has published most often in Clin Cancer Res. Dr. Ho's most frequent co-authors are Richard Joseph, MD, Alan Haruo Bryce, MD and Erik Peter Castle, MD.

Dmand AI links Dr. Ho to 8 clinical trials, 4 of them phase 1/2 studies. Conditions studied include Carcinoma, Renal Cell, Kidney Neoplasms and Bone Neoplasms.

CMS Open Payments shows 263 general payments to Dr. Ho from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Merck Sharp & Dohme Corporation paid the most, $109,353. It also lists 2 research payments totaling $2,235 in 2016.

Dmand AI lists 2 awards for Dr. Ho.

Dr. Ho graduated from Baylor College Of Medicine in 2006. Dr. Ho is a member of AACR, AMA and ASCO.

Dr. Ho is in network with 11 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.